EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) is an AI-enabled medical device from Ever Fortune.AI, Co., Ltd., listed by FDA (510(k), K241923) with a decision date of 2024-12-06. Review panel: Radiology.
| FDA submission number | K241923 |
|---|---|
| Pathway | 510(k) |
| Company | Ever Fortune.AI, Co., Ltd. |
| Review panel (specialty) | Radiology |
| FDA decision date | 2024-12-06 |
| Decision | Substantially Equivalent |
| Product code | QAS |
| Classification | Radiological Computer-Assisted Triage And Notification Software |
| Device class | 2 |
| Regulation number | 892.2080 |
| Review time (calendar days) | 158 |
| Applicant country | TW |
Official FDA database record · FDA AI-enabled device list
More devices from Ever Fortune.AI, Co., Ltd. · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.